tellustherapeutics / Tellus Therapeutics –

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap:

Meta Tags

Title	Tellus Therapeutics –
Description	Tellus Therapeutics is a neonatal care company developing treatments for our most vulnerable About R & D News Contact About R & D News Contact Tellus Therapeutics is a neonatal care company developing treatments for our most vulnerable patient pop
Keywords	N/A

Server Information

WebSite	tellustherapeutics.com
Host IP	107.180.1.230
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

tellustherapeutics.com Valuation

US$1,994,402

Last updated: 2023-05-08 08:13:07

tellustherapeutics.com has Semrush global rank of 5,307,008. tellustherapeutics.com has an estimated worth of US$ 1,994,402, based on its estimated Ads revenue. tellustherapeutics.com receives approximately 230,124 unique visitors each day. Its web server is located in United States, with IP address 107.180.1.230. According to SiteAdvisor, tellustherapeutics.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,994,402
Daily Ads Revenue	US$1,841
Monthly Ads Revenue	US$55,230
Yearly Ads Revenue	US$662,755
Daily Unique Visitors	15,342
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
tellustherapeutics.com.	A	10798	IP: 107.180.1.230
tellustherapeutics.com.	NS	3600	NS Record: ns76.domaincontrol.com.
tellustherapeutics.com.	NS	3600	NS Record: ns75.domaincontrol.com.
tellustherapeutics.com.	MX	3600	MX Record: 0 tellustherapeutics-com.mail.protection.outlook.com.
tellustherapeutics.com.	TXT	3600	TXT Record: v=spf1 include:spf.protection.outlook.com -all

HtmlToTextCheckTime:2023-05-08 08:13:07

About R & D News Contact About R & D News Contact Tellus Therapeutics is a neonatal care company developing treatments for our most vulnerable patient population Preterm infants are our most vulnerable patient population and are at risk for a variety of injuries that can alter normal development. During the neonatal period, the preterm infant brain is in its early stages of development. Factors influencing brain development during this time can have lifelong impacts on a child’s neurologic outcome. Specifically, neonatal events causing inflammation or oxygen deprivation can result in white matter injury (WMI) to the brain, resulting in neurodevelopmental deficits impacting a child’s motor and cognitive abilities. There are currently no treatment options for these infants. Tellus Therapeutics is developing TT-20 for preterm infants at risk for WMI, with the goal of improving neurodevelopmental outcomes for all patients treated. Management Research & Development News About | Research &

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Fri, 29 Oct 2021 16:22:28 GMT
Server: Apache
X-Powered-By: PHP/7.2.34
X-Redirect-By: WordPress
Upgrade: h2,h2c
Connection: Upgrade
Location: http://www.tellustherapeutics.com/
Content-Type: text/html; charset=UTF-8

HTTP/1.1 200 OK
Date: Fri, 29 Oct 2021 16:22:28 GMT
Server: Apache
X-Powered-By: PHP/7.2.34
Link: ; rel="https://api.w.org/", ; rel=shortlink
Upgrade: h2,h2c
Connection: Upgrade
Content-Type: text/html; charset=UTF-8

tellustherapeutics.com Whois Information

Domain Name: TELLUSTHERAPEUTICS.COM
Registry Domain ID: 2303075412_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-08-29T15:15:12Z
Creation Date: 2018-08-28T05:07:39Z
Registry Expiry Date: 2022-08-28T05:07:39Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS75.DOMAINCONTROL.COM
Name Server: NS76.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-17T05:10:25Z <<<

tellustherapeutics.com valuation and analysis